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A B S T R A C T
We have investigated the possibility of using self-assembling peptide-based viscous solutions and
hydrogels as mucoadhesives for the improved delivery of drugs to local mucosal surfaces. The stability of
the samples under ﬂow after deposition on a mucosal surface mimic was studied using a simpliﬁed in
vitromodel. Subsequently lidocaine and ﬂurbiprofen, two commercial drugs, were incorporated into the
viscous solutions and hydrogels and their release properties investigated using the samemodel. Peptide-
based hydrogels showed a good resistance to erosion under ﬂow conditions. Addition of the soluble drug
(lidocaine at low pH) resulted in a stiffening of the samples but did not affect the overall peptide release.
Although for this drug the conditions were not favourable, improved retention of the drug was observed
for the stiffest samples tested. In the case of the insoluble drug (ﬂurbiprofen) the samples mechanical
properties were not altered when the drug was incorporated, however the sample stability and peptide
release were. For mechanically weaker samples the presence of the drug as insoluble small particles
resulted in an increase in their susceptibility to physically erodewhen a ﬂowofmediumwas applied over
its surface. On the other hand mechanically stronger samples showed an improved resistance to erosion,
which resulted in enhanced drug retention.
ã 2014 Elsevier B.V. All rights reserved.
1. Introduction
In the last two decades, signiﬁcant efforts have been made to
develop soft materials based on the self-assembly of peptide for
biomedical applications with a focus on tissue regeneration (Collier
et al., 2010; Gough et al., 2011). Under speciﬁc conditions various
peptide-based systems can self-assemble into ﬁbrillar structures,
which in turn associate and/or entangle to form hydrogels. These
structures are stabilised through a combination of non-covalent
forcessuchasvanderWaals,hydrogenbonding,hydrophobiceffects,
electrostatic interactions or p-stacking of aromatic moieties. By
bringing together building blocks from the variety of amino acids
availableandthedistinctphysicalpropertiesassociatedwith them,a
wide rangeof self-assemblingpeptideswith tuneableproperties can
be designed (Hamley, 2007; Mart et al., 2006).
Based on previous work by Zhang et al., 1993 we recently
developed a range of self-assembling b-sheet forming peptides,
typically 8 amino acids long and based on the alternation of
hydrophobic and hydrophilic amino acids, allowing the design of
hydrogels with tailored properties. In a recent article we described
how these peptides can be used to create hydrogels for drug
delivery (Roberts et al., 2012).
Based on our previous work and the unique properties of these
hydrogels we decided to investigate the possibility of using these
materials as mucoadhesives for local drug delivery. Mucosas are
membrane that lines body cavities or passages that are open to the
external environment such as in the buccal, nasal or vaginal areas.
They are typically coatedwith a gelatinous mixture of proteins and
carbohydrates (mucus). They offer a practical route for efﬁcient
topical delivery of drug as they are relatively permeable.
In this work we focussed on the octapeptide FEFEFKFK (F:
phenylalanine; E: glutamic acid; K: lysine – Fig. 1A) which is well
known to self-assemble into antiparallel b-sheet rich ﬁbres and
forms hydrogels (Fig. 1D) for concentrations in peptide greater
than 20mgmL1 (in water). First the adhesive properties of the
peptide were investigated, subsequently two common drugs –
lidocaine (Fig. 1B) and ﬂurbiprofen (Fig. 1C) – were incorporated
into the hydrogels and their release investigated. For the purpose
of this proof-of-concept work a simplistic in vitro model based on
the one developed by Smart and co-workers (Young and Smart,
1998; Kockisch et al., 2003; Riley et al., 2002) and comprising a
Visking membrane was used. Visking membrane is a dialysis
membrane made of cellulose (polysaccharide), which displays the
elastic and soft properties of a gel whenwet with water, similar to
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mucosa surface. This type of membrane was used successfully as a
model for the oral mucosa in a number of adhesion studies (Bodde
et al., 1990; Smart, 1993). The release proﬁles obtained were
correlated to the viscous and viscoelastic properties of the different
formulations studied. Infrared spectroscopy was also employed in
order to ensure that the peptide conformation was not altered by
the incorporation of drugs into the formulations.
2. Materials and methods
2.1. Materials
Peptides were purchased from Cambridge Research Biochem-
icals (UK) and used without further puriﬁcation. The purity of the
compounds was veriﬁed by HPLC (>90%) and mass spectrometry.
Lidocaine, ﬂurbiprofen and Visking membrane were purchased
from Sigma–Aldrich (UK), Aesica Pharmaceuticals (UK) and
Medicell International (UK) respectively and used as received.
All salts, HPLC grade solvents, deuterated water (99.9 atom% D),
acid and base solutions were purchased from Sigma–Aldrich (UK)
and used as received.
2.2. Sample preparation
Depending on the desired concentration (20–40mgmL–1) the
required amount of peptide was suspended in HPLC grade water.
The sample was vortexed and sonicated (VWR ultrasonicator bath,
30W) until the peptide was fully dissolved (typically for 5–30min
depending on the sample concentration). Due to the presence of
residual triﬂuoroacetic acid (TFA) from the peptide synthesis
samples with ﬁnal pH values of ca. 2–3were obtained. Drug loaded
samples were prepared by mixing the drugs as powders with the
freeze-dried peptide at molar ratios of 1.8:1.0 (20mgmL–1), 1.2:1.0
(30mgmL–1) and 0.9:1.0 (40mgmL–1) for samples with high
loading and 0.9:1.0 (20mgmL–1), 0.6:1.0 (30mgmL–1) and 0.4:1.0
(40mgmL–1) for samples with low loading. The samples were then
stored at room temperature for 12h (overnight) before experi-
ments were performed.
2.3. Fourier transform infrared spectroscopy (FTIR)
Multiple bounce attenuated total reﬂectance (ATR) FTIR experi-
ments were undertaken using samples prepared in deuterated
water. Spectrawere recorded on a Thermo Nicolet 5700 spectrome-
terequippedwithatroughplatecomprisingofazincselenidecrystal.
The sampleswere spread directly on the surface of the trough plate.
Spectrawereacquired in the4000–400 cm1 rangewitha resolution
of4 cm1over256scans.Thedeuteratedwaterspectrumwasusedas
background and subtracted from all spectra (software used: Omnic
version 7.2, Thermo Electron Corporation).
2.4. Dynamic shear rheometry
Viscous and viscoelastic properties were assessed using a
stress-controlled rheometer (TA Instruments AR-G2) equipped
with a Peltier plate to control temperature. A parallel plate
geometry was used with a diameter of 20mm. For viscosity
measurements (viscous samples) the apparatus was used in a ﬂow
mode. The viscosity of the samples was measured as a function of
shear rate in the range 0.01–1000 s–1. For viscoelastic measure-
ments (gel samples) the apparatuswas used in an oscillatorymode.
To ensure the measurements were made in the linear viscoelastic
regime (LVR), amplitude sweeps were performed and showed no
variation in G0 and G00 up to a strain of 1%. The dynamic moduli of
the hydrogels were therefore measured as a function of frequency
in the range 0.1–100 rad s–1 at a strain of 0.1%. In both modes, all
experiments were performed at 25 C and repeated at least three
times to ensure reproducibility. Unless stated otherwise all
viscosities and moduli mentioned in the text are taken at a shear
rate of 1 s1 and an angular frequency of 10 rad s1.
2.5. Salt solution preparation
Salt solution was prepared according to the formulation
described in reference (Diem and Lentner,1972). Sodium hydrogen
carbonate (0.42 g), sodium chloride (0.43 g), potassium chloride
(1.49 g) and sodium dihydrogen phosphate dihydrate (1.03 g) were
dissolved in HPLC grade water (1 L). Calcium chloride dihydrate
(0.22 g) was then added to the solution, which was vigorously
agitated until complete dissolution of the salt. The solution was
stored at 4 C. The ﬁnal pH of the medium was 6.500.05.
2.6. Stability in excess medium
The stability of the peptide formulations was assessed in static
conditions. A glass slide was covered with a Visking (cellulose)
[(Fig._1)TD$FIG]
Fig.1. Chemical structure of (A) FEFEFKFK peptide, (B) lidocaine and (C) ﬂurbiprofen. (D) Diagrammatic representation of the self-assembly and gelationprocesses ofb-sheet
forming peptides.
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permeable membrane (12,000–14,000Da) pre-washed in warm
water and placed in a container. Four hundred microlitres of
samples were pipetted onto the membrane and left to settle down
for 10min before being covered with 10mL of water or salt
solution. The behaviour of the systems in the presence of excess
medium was then observed at different time points.
2.7. Release proﬁle and retention study
The mucoadhesive properties of the peptide-based formula-
tions were assessed using a simpliﬁed in vitro retention model
(Fig. 2) based on the model developed by Smart and co-workers
(Young and Smart, 1998; Kockisch et al., 2003; Riley et al., 2002).
Themodelwas constituted of a rampwith a 30 slope and a Visking
membrane (12,000–14,000Da, 1.55 cm), which was used to
mimic mucosa surfaces. The membrane was pre-washed in warm
water and conditioned in salt solution for 5min prior to
experimentation. The membrane was then blotted on Whatman
50 ﬁlter paper and placed onto the ramp. One hundred microlitres
of the formulation was deposited onto the membrane using the
syringe and left to settle down for 1min before a ﬂow (2mLmin–1,
37 C) of salt solution was started using a peristaltic pump
(Watson–Marlow 323S). Fractions were collected every 10min,
topped up with 30mL of either acetonitrile (samples loaded with
lidocaine or unloaded) or methanol (samples loaded with
ﬂurbiprofen) and sonicated. At the end of the experiments any
sample remaining on themembranewas recovered bywashing the
latter using the appropriate solvent (see above). All experiments
were performed at least three times. The cumulative release, Rcum,
at time t was calculated using the following equation:
RcumðtÞ ¼
Pt
i¼0
Mi
M1
 100 (1)
whereMi is the mass of compound (peptide or drug) released after
each time interval (10min) andM1 is the total mass of compound
deposited on the membrane. M1 was calculated through:
M1 ¼
XtðexpÞ
i¼0
Mi þMend (2)
where t(exp) is the total time length of the experiment andMend is
the mass of compound left on the membrane at the end. This
approach allowed us to correct for any sample volume error due to
material left in the syringe when depositing the sample on the
membrane.
2.8. High-performance liquid chromatography (HPLC)
Quantiﬁcation of the amounts of peptide and drug released
were performed by HPLC. Chromatograms were recorded using
Chromeleon software (version 6.80) on a Dionex Ultimate 3000
system consisting of an LPG-3400A pump connected to an ACC-
3000 automated sample injector and equipped with a VWD-3400
UV detector. Each fraction was centrifuged at 5000 rpm for 5min
and ﬁltered using 0.45mm pore ﬁlters prior to HPLC analysis. For
quantiﬁcation purposes calibration curves were established for
each compound (peptide and drugs) against which peak retention
times and peak areas were compared.
The amount of peptide released was quantiﬁed by monitoring
the absorbance of the peptide bonds at a wavelength of 210nm.
Aliquots of 80mL were injected with a ﬂow rate of 1.5mLmin–1 at
25 C into a Spherisorb XBridge C4 column (length: 250mm,
diameter: 4.6mm) containing particles (diameter: 3.5mm, pore
diameter: 300Å). The gradient used was a linear exchange
between water/acetonitrile (80:20, 0.1% TFA) at the start to
water/acetonitrile (62:38, 0.1% TFA) at 9min.
The amount of lidocaine released was quantiﬁed bymonitoring
its absorbance at a wavelength of 220nm. Aliquots of 20mL were
injected with a ﬂow rate of 2.0mLmin–1 at 35 C into a Waters
Spherisorb SCX cartridge (length: 100mm, diameter: 4.6mm)
containing silica particles (diameter: 5mm, pore diameter: 80Å).
The mobile phase used was an acetonitrile/buffer (60:40) mixture.
The buffer was constituted of potassium dihydrogen orthophos-
phate (0.5 g) and orthophosphoric acid (3mL) dissolved in water
(1 L). The pH of the buffer was adjusted to 2.5 using ammonia.
The amount of ﬂurbiprofen released was quantiﬁed by
monitoring the absorbance at a wavelength of 280nm. Aliquots
of 80mL were injectedwith a ﬂow rate of 1.5mLmin–1 at 25 C into
a Waters Symmetry C18 column (length: 100mm, diameter:
4.6mm) containing silica particles (diameter: 3.5mm, pore
diameter: 100Å). The mobile phase used was a methanol/water
(66:34, 1% orthophosphoric acid) mixture.
For the loaded samples drug and peptide quantiﬁcations were
carried out using the same fractions. Due to differences in
solubility, samples containing ﬂurbiprofen were placed at 45 C
for several days until complete evaporation of their methanol/salt
solution content. The solvent mixture was then replaced by an
equal volume of acetonitrile/water (60:40) mixture and the
amount of peptide released quantiﬁed as described above.
3. Results and discussion
3.1. Part 1: Peptide release
FEFEFKFK peptides were dissolved inwater at concentrations of
20, 30 and 40mgmL–1 as described above. Viscous liquids were
found to form for the 20 and 30mgmL1 samples while self-
supported hydrogels formed for the 40mgmL1 sample suggesting
that the critical gelation concentration (CGC) of this peptide lies in
between 30 and 40mgmL1. This is slightly higher than the CGC
observed in our previous work for the same peptide (Saiani et al.,
2009). The difference in CGC is thought to be due to different
methods of preparation used. Indeed here the peptides were
dissolved through sonication instead of heating. The exact reason
for the difference in CGC obtained by changing the dissolution
method is outside the scope of this article and will be discussed
elsewhere.
First the viscous properties of the samples were assessed. In
these experiments, a continuous shear was applied and viscosity
measured as a function of shear rate. As can be seen from Fig. 3A
the viscosity of the samples was found to increase with increasing
[(Fig._2)TD$FIG]
Fig. 2. (A) Schematic representation of the in vitro retention model used. (B) Photograph of a sample (dyed for better visualisation) on the in vitro retention model.
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peptide concentration, in agreement with their macroscopic
consistency. For all samples the viscosity was also found to
decrease signiﬁcantly with increasing shear rate, showing shear-
thinning behaviour. Since a self-supporting gel rather than a
viscous liquid was obtained for the 40mgmL–1 sample, its
viscoelastic properties were also evaluated. In contrast with
viscosity experiments, here small amplitude deformations within
the LVR were applied to avoid “breaking” the hydrogel. As can be
seen from Fig. 3B the storage modulus, G0, was found to be higher
than the loss modulus, G00, and a weak dependency of the gel
moduli with frequency was observed. This type of mechanical
response is typical of weak hydrogels (Ross-Murphy, 1995).
Initially stability of the samples when immersed in water and
salt solution was investigated by pipetting the 30mgmL–1 viscous
sample onto pre-conditioned Visking membranes and then
immersing the latter in excess medium (Fig. 4A and B). Immersion
in salt solution led to the swelling and gelation of the sample with
time, resulting in the formation of a swollen gel after 16h (Fig. 4D).
Immersion in water, on the other hand, resulted in progressive
dissolution of the sample and after 16h no sample was left on the
membrane (Fig. 4C). The greater stability of the sample when
immersed in salt solution is thought to be due to the ionic strength
of the medium (ca. 80mM). Indeed it is well known that medium
ionic strength and pH affect the gelation properties of this family of
peptides (Ozbas et al., 2004). As discussed elsewhere (Roberts
et al., 2012), the presence of ionic species in the medium leads to
screening of the charges carried by the peptide ﬁbres, resulting in a
decrease in the ﬁbre–ﬁbre electrostatic repulsion. This behaviour
leads to an increase in ﬁbre lateral association, which results in
“stronger” network junctions and stiffer hydrogels. Here it is
believed that when the sample is immersed in salt solution the
medium diffuses in the sample, resulting in its gelation. In order to
conﬁrm the gel strengthening property of the salt solution,
samples were prepared using this medium instead of water. In this
case self-supporting hydrogels were obtained, as conﬁrmed by
rheometry (Figure S1), at all three concentrations and in the case of
the 40mgmL–1 sample a hydrogel with a signiﬁcantly higher G0
was obtained compared to the same gel prepared in water
(Table 1).
The mucoadhesive properties of the peptide hydrogels were
assessed using a simpliﬁed version of the in vitro retention model
developed by Smart and co-workers (Kockisch et al., 2003; Riley
et al., 2002) (Fig. 2A). Thismodel was designed to produce a ﬂowof
a salt solution over the samples to investigate its effect on their
degradation and release properties. To form a thin pellicle on top of
the membrane, the membrane was conditioned in salt solution for
a few minutes and the solution excess allowed to ﬂow off the
membrane before depositing the samples. The extent of peptide
[(Fig._3)TD$FIG]
Fig. 3. (A) Viscosity proﬁle of FEFEFKFK samples at 20, 30 and 40mgmL–1 prepared in water. (B) Dynamic frequency sweep of FEFEFKFK at 40mgmL–1 prepared in water.
[(Fig._4)TD$FIG]
Fig. 4. Photographs of FEFEFKFK sample prepared inwater at 30mgmL–1, deposited
on Visking membranes and subsequently immersed in excess water (A) and in
excess salt solution (B). Photographs of samples on the Visking membranes
following removal of excess water (C) and salt solution (D) after 16h of immersion.
Table 1
Values of the apparent viscosity, h, at 1 s–1 and storage modulus, G0 , at 10 rad s–1 for
the studied systems.
System Water Salt
solution
h (Pa s) G0 (Pa) G0 (Pa)
FEFEFKFK 40mgmL–1 17.40.2 203 14715
FEFEFKFK 30mgmL–1 1.52 926
FEFEFKFK 20mgmL–1 0.30.1 8610
FEFEFKFK 40mgmL–1 + lidocaine 7.4mgmL–1 7210
FEFEFKFK 30mgmL–1 + lidocaine 7.4mgmL–1
FEFEFKFK 20mgmL–1 + lidocaine 7.4mgmL–1 18.40.2
FEFEFKFK 40mgmL–1 + lidocaine 3.7mgmL–1 344
FEFEFKFK 30mgmL–1 + lidocaine 3.7mgmL–1 3.90.1
FEFEFKFK 20mgmL–1 + lidocaine 3.7mgmL–1 1.70.1
FEFEFKFK 40mgmL–1 +ﬂurbiprofen 7.7mgmL–1 337
FEFEFKFK 30mgmL–1 +ﬂurbiprofen 7.7mgmL–1 3.00.1
FEFEFKFK 20mgmL–1 +ﬂurbiprofen 7.7mgmL–1 0.50.1
FEFEFKFK 40mgmL–1 +ﬂurbiprofen 3.9mgmL–1 437
FEFEFKFK 30mgmL–1 +ﬂurbiprofen 3.9mgmL–1 2.30.1
FEFEFKFK 20mgmL–1 +ﬂurbiprofen 3.9mgmL–1 0.60.1
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release from the deposited samples was monitored over 2h by
HPLC.
During the ﬁrst 10–20min a visible “stiffening” of the samples
on the membrane was observed. As the salt solution ﬂowed over
the samples’ surface it diffused into them leading, as discussed
above, to their gelation/stiffening. The peptide cumulative release
proﬁles are presented in Fig. 5. As can be seen, in particular for the
20mgmL–1 sample, the peptide release rates (curve tangent) were
higher at the start of the experiment and then decreasedwith time,
becoming constant after 1h. At the start of the experiments the
mechanical properties of the samples were those of samples
prepared in water. After 60min it is reasonable to assume that
most of the water medium within the samples had been replaced
by the salt solution and therefore the mechanical properties of the
samples at that point in time were expected to be close to those of
samples prepared in salt solution (Table 1). The decrease in peptide
release rates observed during the ﬁrst 60min could therefore be
explained by the gelation/stiffening of the samples. This effect was
expected to me more marked for samples with lower peptide
concentration as their mechanical properties at the start of the
experiments were “weaker”, making them more prone to the
mechanical erosion/degradation of their surfaces by the salt
solution ﬂow. Indeed for the 20mgmL–1 sample signiﬁcant
peptide release was observed during the ﬁrst 10min and as the
sample became stiffer the peptide release rate decreased
signiﬁcantly. For the 30 and 40mgmL–1 samples this effect was
much less pronounced suggesting that these samples’ strength at
the start was enough to prevent signiﬁcant mechanical erosion of
the sample surface. In these cases the peptide release rates were
found to decreasemarginally on stiffening of the samplewith time.
After 60min the peptide release rates became constant and
release rates of 0.40, 0.20 and 0.300.05mgmin–1 were obtained
for the 20, 30 and 40mgmL–1 samples respectively. From 1h
onwards, it is thought that the strength of the samples is sufﬁcient
to prevent the mechanical erosion of their surfaces by the salt
solution ﬂow, resulting in relatively low peptide release rates. After
2h thin gel layers were still present on the surface of the Visking
membrane for all the samples, suggesting that there was a good
adhesion of the samples onto the membrane. Cumulative releases
of 68, 30 and 39% were observed after 2h for the 20, 30 and
40mgmL–1 samples respectively. At these latter stages of the
experiments the sample degradation process is thought to be
driven by the dissolution and diffusion of the peptide from the gels’
surface layer into the salt solution ﬂow. This process is expected to
be controlled by a number of factors, including the porosity and
hydrophobicity of the sample and its peptide concentration. As the
samples’ peptide concentration was increased, the gel ﬁbrillar
network porosity was reduced (Saiani et al., 2009) while the
samples’ overall hydrophobicity was increased. Both these factors
would result in a decreased ability of the salt solution to diffuse
into the sample, and therefore a decrease in the driving force for
the peptide to dissolve and diffuse out into the salt solution ﬂow.
On the other hand, the increase in peptide concentration would
increase the driving force for the peptide to dissolve and diffuse out
through an increase of the osmotic pressure. These two opposing
mechanisms are thought to be at the origin of the decrease in
peptide release rates between the 20 and 30mgmL–1 samples and
marginal increase in release rates between the 30 and 40mgmL–1
samples respectively.
3.2. Part 2: Lidocaine release
Next, the hydrogels were loaded with lidocaine, a local
anaesthetic (pKa = 7.9), at concentrations of 7.4 and 3.7mgmL1
(Mather and Thomas, 1972). Under the conditions used here
lidocaine was found to be soluble and transparent loaded samples
were obtained. The viscosity proﬁles and moduli of the 20 and
40mgmL1 unloaded and loaded samples are presented in Fig. 6A
and B respectively. A signiﬁcant increase in the 20mgmL1 sample
viscosity at low shear rates was observed upon addition of
lidocaine. For the sample with the high drug payload a weak self-
supporting hydrogel was actually obtained. Similarly for the
40mgmL1 sample a signiﬁcant increase in the shearmoduluswas
observed upon loading the hydrogels with lidocaine. These results
showed that addition of lidocaine strengthened the samples.
When prepared inwater the samples had a pH of 2–3 due to the
presence of residual TFA, originating from the peptide synthesis. At
this pH lidocaine carries a net charge of +1 while the peptide
carries a net charge of +2 to +3 (Roberts et al., 2012). Electrostatic
interactions are therefore expected to be present between the drug
molecules and the peptide ﬁbres. The effect of adding charged
guest molecules to this family of peptide hydrogels has been the
subject of a recent article from our group (Roberts et al., 2012). We
showed that adding small charged guest molecules does not affect
the self-assembly of the peptides at a molecular level. This
behaviour was conﬁrmed for the samples under discussion here by
FTIR (Figure S2). No difference was observed in the FTIR spectra
obtained for the loaded and unloaded samples. A strong absorption
band at 1625 cm–1 and a small shoulder at 1694 cm–1 were
observed with the same intensities for all the samples, indicating
that the peptide adopted an antiparallel b-sheet conformation. On
the other handwehave previously shown (Roberts et al., 2012) that
[(Fig._5)TD$FIG]
Fig. 5. Release proﬁles corresponding to the average cumulative release of peptide from FEFEFKFK samples at 20 (&), 30 (~) and 40 (*) mgmL–1 prepared in water.
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the presence of charged guest molecules does affect the topology
of the ﬁbrillar network formed and therefore the mechanical
properties of the hydrogels which is thought to be the case here
too. The detailed investigation of the effect of lidocaine addition on
the peptide ﬁbrillar network is outside the scope of this article.
This topic was discussed in detail elsewhere (Roberts et al., 2012),
however it should be noted that the drug payloads used in the
present work are signiﬁcantly higher than those used in our
previous work.
The release of lidocaine and peptide was investigated over 1h
using the same in vitro model as above. The cumulative drug
release proﬁles are presented in Fig. 7. The peptide release proﬁles
(Figure S3) were similar to those obtained for the unloaded
samples (Fig. 5), indicating that the presence of the drug did not
[(Fig._7)TD$FIG]
Fig. 7. Release proﬁles corresponding to the average cumulative release of peptide (open symbols) and drug (plain symbols) from FEFEFKFK samples at 20 (&,&), 30 (4,~)
and 40 (, *) mgmL–1 prepared in water, loaded with (A) 7.4 and (B) 3.7mgmL–1 of lidocaine.
[(Fig._6)TD$FIG]
Fig. 6. (A) Viscosity proﬁles of FEFEFKFK samples at 20mgmL–1 prepared inwater, unloaded and loaded with lidocaine at 7.4 and 3.7mgmL–1. (B) Dynamic frequency sweep
of FEFEFKFK samples at 40mgmL–1 unloaded and loaded with lidocaine at 7.4 and 3.7mgmL–1. Error bars have been omitted for clarity.
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affect the rate at which the peptide hydrogels were degraded by
the salt solution ﬂow. As far as lidocaine is concerned, the highest
retentionwas observed for the stiffer gels (30 and 40mgmL1 with
high loading), with 90% of the drug being released after 40–50min.
For the weak gels (40mgmL1 with low loading and 20mgmL1
with high loading), a faster release of the drug was observed with
90% of lidocaine being release after 30–40min. Finally, the fastest
drug release was observed for the weakest samples (20 and
30mgmL1 with low loading), which were actually viscous
solutions at the beginning of the experiment. In this case 90% of
the drug was released during the ﬁrst 10min of the experiment.
These results show that the samples mechanical property is the
main factor controlling the release of lidocaine. Lidocaine being
soluble under the conditions used here, its release is mainly driven
by its ability to diffuse out of the hydrogels and into the salt
solution ﬂow. As mentioned above, under the acidic pH conditions
used here, both the drug and the peptide ﬁbres carry positive
charges and therefore electrostatic repulsions are expected
between the drug molecules and the peptide ﬁbres. This favours
the release of the drug from the hydrogels, as shown in our
previous work (Roberts et al., 2012). As a consequence, the ability
of the drug to diffuse out ismainly controlled by the stiffness of the
hydrogels. It should be noted that in the peptide concentration
range used here the typical porosity of the peptide network is
20–30nm (Saiani et al., 2009), which is signiﬁcantly larger than the
drug molecule. The effect of the relatively small reduction in gel
porosity when increasing the sample concentration from 20 to
40mgmL1 is therefore not expected to affect the ability of
lidocaine to diffuse out of the hydrogels. This assumption was
conﬁrmed by the release proﬁle obtained being dependent only on
the mechanical properties of the hydrogels and not on the peptide
concentration or the drug loading (in the peptide concentration
and drug loading ranges investigated). The stiffening of the
samples simply reduced the ability of the drug to diffuse out into
the salt solution ﬂow.
3.3. Part 3: Flurbiprofen release
Next the samples were loaded with ﬂurbiprofen, a non-
steroidal anti-inﬂammatory drug (pKa = 4.2) (Meloun et al.,
2007), at concentrations of 7.7 and 3.9mgmL1. Flurbiprofen is
a highly insoluble drug (intrinsic solubility in water of 0.01mg
mL–1) and when mixed with water it precipitates out of solution.
When the drug was mixed with the peptide and both concomi-
tantly added to water, ﬁne drug suspensions were obtained,
showing the ability of the peptide to disperse the drug.
In this case the loading of the drug did not affect signiﬁcantly
the mechanical properties of the samples. As can be seen from
Fig. 8A a slight increase in the 20mgmL1 sample viscosity at low
shear ratewas observed upon incorporation of the drug. Similarly a
slight increase in the 40mgmL1 samplemodulus was observed at
low frequencies (Fig. 8B). Under the pH conditions used here
ﬂurbiprofen was not charged and therefore in this case electro-
static interactions between the drug molecules and the peptide
ﬁbres were not expected. In addition, the drug was present in the
gel mainly as a ﬁne suspension of insoluble particles and therefore
signiﬁcant interactions at the molecular level, such as hydrogen
bonding, were not expected either. Again, FTIRwas used to conﬁrm
that the addition of the drug did not affect the self-assembly of the
peptide. Spectra similar to those of the unloaded sampleswere also
obtained for the ﬂurbiprofen loaded samples (Figure S2).
The peptide and drug release proﬁles are presented in Fig. 9. In
this case the presence of the drug was found to affect the release of
the peptide. For the 20mgmL1 with low loading sample the
peptide release was found to increase signiﬁcantly over the ﬁrst
20min in the presence of ﬂurbiprofen, with 40% of the peptide
being released over 20min compared to 20% for the unloaded
sample (Fig. 5). In the same time period 80% of the drug payload
was released. From 30min onwards, after the majority of the drug
had been released, the peptide release rates for loaded and
unloaded samples (Figure S4) became similar as onewould expect.
Viscous solutions were obtained for the 20mgmL1 samples
(loaded and unloaded)whenprepared inwater and the presence of
the drug asﬁne suspended insoluble particleswas thought to affect
the sample mechanical stability, making its surface more prone to
erosion by the salt solution ﬂow and resulting in higher peptide
and drug release rates. The drug release rate was however found to
be signiﬁcantly higher compared to that of the peptide. Peptide
molecules were incorporated into tridimensional (3D) b-sheet
ﬁbrillar networks, making their dissolution in the medium more
difﬁcult as the peptides were held together within the ﬁbres
through hydrogen bonding. On the other hand the drug was
present in the sample as free standing small particles which made
themmore prone to being dissolved and/or washed out by the salt
solution medium.
For the 40mgmL1 samples the opposite effect was observed
and the peptide release rates were found to decrease signiﬁcantly
upon addition of the drug (Figure S4), with 5% of peptide being
released after 1h compared to 20% for the unloaded sample (Fig. 5).
Over the same time period only 40% of the drug was released,
showing signiﬁcant drug retention. In this case it is thought that
the mechanical strength of the hydrogels was high enough to
[(Fig._8)TD$FIG]
Fig. 8. (A) Viscosity proﬁles of FEFEFKFK samples at 20mgmL–1 prepared inwater, loadedwith ﬂurbiprofen at 7.7 and 3.9mgmL–1. (B) Dynamic frequency sweep of FEFEFKFK
samples at 40mgmL–1 unloaded and loaded with ﬂurbiprofen at 7.7 and 3.9mgmL–1. Error bars have been omitted for clarity.
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prevent their mechanical destabilisation by the insoluble small
drug particles and therefore no signiﬁcant mechanical erosion of
the sample surface was thought to occur. The drug and peptide
release still occurred through dissolution of the individual
components and their diffusion into the salt solution ﬂow. The
decrease of the peptide release rate compared to that of the
unloaded samples was thought to be due to the signiﬁcant increase
in sample hydrophobicity upon addition of the drug. This is
expected to result in a reduction of the ability of the salt solution to
diffuse in the sample and hence in a reduction of the peptide and
drug release. For this sample the drug release ratewas signiﬁcantly
reduced compared to that of the 20mgmL1 sample although for
the same reason as discussed above it was still higher than the
peptide release rate.
For the 30mgmL1 samples an intermediate situation between
the two samples discussed above was observed. For the sample
with low loading the peptide release was found to decrease
signiﬁcantly and improved drug retentionwas observed compared
to what was obtained for the 20mgmL1 loaded samples. As for
the 40mgmL1 loaded samples the strength of the sample was
thought to be sufﬁcient to prevent its mechanical destabilisation
by the presence of the drug particles and therefore no signiﬁcant
surface erosion was thought to occur. On the other hand, for the
sample with high payload the amount of drug was high enough to
mechanically destabilise the sample, leading to its surface
mechanical erosion by the salt solution ﬂow. As a result, signiﬁcant
increase in the peptide release was observed, compared to the
unloaded sample (Fig. 5). This assertion is supported by the fact
that signiﬁcant release was observed during the ﬁrst 10–20min of
the experiment when the sample was at its weakest. In this case a
drug release proﬁle similar to that of the 20mgmL1 sample was
observed.
4. Conclusion
We have investigated the possibility of using self-assembling
peptide-based viscous solutions/hydrogels as mucoadhesives for
the topical delivery of drugs using a simpliﬁed in vitro model. In
this work we focussed on the FEFEFKFK peptide.
The diffusion of salt solution into the samples led to an
increased mechanical strength and stability, resulting in improved
resistance of the samples surface to physical erosion. The samples
showed a good resistance to the salt solution ﬂow with the
40mgmL1 sample having released only30% of its initial peptide
content after 2h.
We then studied the release of two commercial drugs, lidocaine
(soluble under conditions used in the present work) and
ﬂurbiprofen (insoluble). As far as licodaine was concerned the
addition of the drug was shown to result in a stiffening of the
samples. Under the pH conditions tested both drug and peptide
ﬁbres were carrying positive charges. Although drug retentionwas
not favoured (drug and peptide carrying charges of the same sign)
improved drug retention was observed for stiffer samples. As
shown in our previous work the use of a peptide carrying negative
charges could potentially result in a signiﬁcant improvement in
drug retention.
[(Fig._9)TD$FIG]
Fig. 9. Release proﬁles corresponding to the average cumulative release of peptide (open symbols) and drug (plain symbols) from FEFEFKFK samples at 20 (&,&), 30 (4,~)
and 40 (, *) mgmL–1 prepared in water, loaded with (A) 7.7 and (B) 3.9mgmL–1 of ﬂurbiprofen.
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The addition of ﬂurbiprofen to the samples was shown not to
signiﬁcantly affect the samples mechanical properties. For the
samples with the weakest mechanical properties the presence of
this drug as a ﬁne suspension of insoluble particles was shown to
reduce their resistance to physical erosion by salt solution ﬂow. On
the other hand when the samples initial mechanical properties
were high enough the addition of the drug resulted in a signiﬁcant
improvement of their resistance to erosion. In this case very good
sample stability and drug retentionwere observed, in particular for
the 40mgmL1 sample, which showed only 40% of drug and 5% of
peptide release into the salt solution ﬂow after 1h.
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